✨ Medicines Consent Notices




NEW ZEALAND GAZETTE

28 NOVEMBER

Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any)

--- | --- | --- | ---
Clarithromycin 500 mg | Tablet | Abbott Australasia Pty Limited, Kurnell, New South Wales, Australia; Abbott Laboratories Limited, Queenborough, Kent, England and Abbott SpA., Campoverde di Aprilia, Latina, Italy | Maclar

Flurbiprofen sodium 0.3 mg/mL in 0.4 mL | Eye drops | Allergan Pharmaceuticals (Ireland) Limited, Westport, County Mayo, Ireland | Ocufen Unit Dose Eye Drops

Vincristine sulphate 1 mg/1 mL, 2 mg/2 mL | Injection, pre-filled syringe | Eli Lilly International Corporation, Indianapolis, Indiana, United States of America and Lilly France S.A., Fegersheim, France | Oncovin Solution

Fluoxetine 20 mg | Tablet, dispersible | Eli Lilly & Company, Basingstoke, Hants, England; Eli Lilly International Corporation, Indianapolis, Indiana, United States of America and Lilly Espana S.A., Alcobendas, Madrid, Spain | Prozac 20

Dated this 22nd day of November 1996.

KAREN O. POUTASI (DR), Director-General of Health, pursuant to delegation given by the Minister of Health on the 18th day of January 1996.

g07705

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any)

--- | --- | --- | ---
Dicloxacillin sodium, anhydrous 559 mg, 1.117 g, 2.235 g equivalent to 500 mg, 1 g, 2 g dicloxacillin respectively | Powder for injection, vial | Bristol-Myers Squibb SpA., Sermoneta, Latina, Italy | Diclocil

Dicloxacillin sodium, anhydrous equivalent to 62.5 mg/5 mL, 125 mg/5 mL dicloxacillin in 100 mL | Powder for oral suspension | Bristol-Myers Squibb SpA., Sermoneta, Latina, Italy | Diclocil

Dicloxacillin sodium, anhydrous 275 mg, 551 mg, equivalent to 250 mg, 500 mg dicloxacillin respectively | Capsules | Bristol-Myers Squibb SpA., Sermoneta, Latina, Italy | Diclocil

Tamoxifen citrate 10 mg, 20 mg | Tablets | Egis Pharmaceuticals, Budapest, Hungary | Estroxin

Insulin lispro (rDNA origin) 100 U/mL in 10 mL | Injection, vial | Lilly France S.A., Fegersheim, France | Humalog

Insulin lispro (rDNA origin) 100 U/mL in 1.5 mL | Injection, cartridge | Lilly France S.A., Fegersheim, France | Humalog

Each 0.5 mL dose contains 8 mcg formalin treated 69 kDa outer membrane protein of B. pertussis, NLT 30 IU adsorbed diphtheria toxoid, 25 mcg formalin treated filamentous haemagglutinin, 25 mcg detoxified pertussis toxin, and NLT 40 IU adsorbed tetanus toxoid | Vaccine, prefilled syringe | Sachsisches Serumwerk GmbH., Dresden, Germany and SmithKline Beecham Biologicals, Rixensart, Belgium | Infanrix

Each 0.5 mL dose contains 8 mcg formalin treated 69 kDa outer membrane protein of B. pertussis, NLT 30 IU adsorbed diphtheria toxoid, 25 mcg formalin treated filamentous haemagglutinin, 25 mcg detoxified pertussis toxin, and NLT 40 IU adsorbed tetanus toxoid | Vaccine, vial | Sachsisches Serumwerk GmbH., Dresden, Germany and SmithKline Beecham Biologicals, Rixensart, Belgium | Infanrix



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1996, No 171


NZLII PDF NZ Gazette 1996, No 171





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of Changed Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
22 November 1996
Medicines Act 1981, Medicines, Distribution, Clarithromycin, Flurbiprofen sodium, Vincristine sulphate, Fluoxetine
  • KAREN O. POUTASI (DR), Director-General of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
Medicines Act 1981, New Medicines, Distribution, Dicloxacillin sodium, Tamoxifen citrate, Insulin lispro, Vaccine